US Stock MarketDetailed Quotes

EYEN Eyenovia

Watchlist

0.760
-0.048-5.89%

Close Jun 3 16:00 ET

40.96MMarket Cap-1027P/E (TTM)

Eyenovia Stock Forum

Trytosaveabit

May 16 19:45

Again! Wish I had faith in analysts! Hehehe

$Eyenovia(EYEN.US)$ HC Wainwright & Co. Reiterates Buy on Eyenovia, Maintains $12 Price Target

Trytosaveabit

May 16 04:07

$Eyenovia(EYEN.US)$ Eyenovia (NASDAQ:EYEN) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.17) by 35.29 percent. This is a 53.33 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $4.993 thousand which missed the analyst consensus estimate of $816.667 thousand by 99.39 percent.

Trytosaveabit

May 16 04:03

Update

$Eyenovia(EYEN.US)$ Reuters· just
Eyenovia Inc - Requested Meeting With FDA to Discuss Validation of the Gen-2 Dispenser, Which We Anticipate Will Occur This Summer

Trytosaveabit

May 16 02:51

$Eyenovia(EYEN.US)$ Well im taking this for a earnings spin! Hehehe! Wish me luck! I know that next Q will probably be much better because of some things not yet settled? But i really like it and if my earnings spin crashes? Well no harm because ive traded it before and i like it! So ill just swing it! Hehehe! NFA

JESSE JAMES8832

Apr 26 19:46

maybe a nice uptrend starting !? way to early tto tell

$Eyenovia(EYEN.US)$

Trytosaveabit

Apr 26 03:28

$Eyenovia(EYEN.US)$ Ok i will make you a deal! If you break 1.00? Whether that be today or soon. I will buy more! Even if i sell my whole position, ill buy right back at a buck! I mean thats a pretty good deal for you? Hehehe

Trytosaveabit

Apr 25 19:39

Update

$Eyenovia(EYEN.US)$ Eyenovia Provides Clinical and Scientific Update On FDA-Approved Products Mydcombi And Clobetasol Propionate Ophthalmic Suspension
Benzinga· 1 min ago
Company announces results from a Phase IV study of Mydcombi designed to characterize the efficacy and duration of the lowest deliverable dose (one 8μL spray per eye)
Also announces upcoming ARVO presentation on the unique technology behind clobetasol that allows for future ophthalmic suspensions to be dispensed with the O...

101674396

Apr 16 15:25

$Eyenovia(EYEN.US)$ .. Write time to bought now? 0.55, any experts, if please advice.

Trytosaveabit

Apr 10 02:05

That wasn’t what I was thinking when they said exploring options to “ MAXIMIZE SHAREHOLDER VALUE”

$Eyenovia(EYEN.US)$ Hehehe! Company entered into a purchase agreement with a “ Fundementals-Based Healthcare Investor “by selling 3,223,726 shares at .6204! Yes they are using the money to complete the CHAPERONE PEDIATRIC MYOPIA Clinical Study! But how at that price does it increase shareholder value? Well at least in the short term it hurts! Study does great? Yes it will help! But .91 down to .57! ...

Trytosaveabit

Apr 8 19:08

Update

$Eyenovia(EYEN.US)$ Eyenovia Initiates Process To Explore Strategic Alternatives To Maximize Shareholder Value
Benzinga· 5 mins ago
The company announced its plans for accelerating development of its potential multi-billion dollar product for pediatric progressive myopia (MicroPine). In conjunction with the strategic process and focus on its late stage MicroPine asset, Eyenovia reiterated its immediate commercialization opportunities and corporate savings intended to reduce operating expen...

No comment yet

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

Concept

Top Gainers Yesterday

Intraday+0.46%